Crossref journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
Abstract

The short life span of granulocytes, which limits many inflammatory responses, is thought to be influenced by the Bcl-2 protein family, death receptors such as CD95 (Fas/APO-1), stress-activated protein kinases such as p38 mitogen-activated protein kinase (MAPK), and proinflammatory cytokines like granulocyte colony-stimulating factor (G-CSF). To clarify the roles of these various regulators in granulocyte survival, we have investigated the spontaneous apoptosis of granulocytes in culture and that induced by Fas ligand or chemotherapeutic drugs, using cells from normal, CD95-deficient lpr, or vav-bcl-2 transgenic mice. CD95-induced apoptosis, which required receptor aggregation by recombinant Fas ligand or the membrane-bound ligand, was unaffected by G-CSF treatment or Bcl-2 overexpression. Conversely, spontaneous and drug-induced apoptosis occurred normally in lpr granulocytes but were suppressed by G-CSF treatment or Bcl-2 overexpression. Although activation of p38 MAPK has been implicated in granulocyte death, their apoptosis actually was markedly accelerated by specific inhibitors of this kinase. These results suggest that G-CSF promotes granulocyte survival largely through the Bcl-2–controlled pathway, whereas CD95 regulates a distinct pathway to apoptosis that is not required for either their spontaneous or drug-induced death. Moreover, p38 MAPK signaling contributes to granulocyte survival rather than their apoptosis.

Bibliography

Villunger, A., O’Reilly, L. A., Holler, N., Adams, J., & Strasser, A. (2000). FAS Ligand, Bcl-2, Granulocyte Colony-Stimulating Factor, and p38 Mitogen-Activated Protein Kinase. The Journal of Experimental Medicine, 192(5), 647–658.

Authors 5
  1. Andreas Villunger (first)
  2. Lorraine A. O'Reilly (additional)
  3. Nils Holler (additional)
  4. Jerry Adams (additional)
  5. Andreas Strasser (additional)
References 69 Referenced 85
  1. {'key': '2023072509304597200_R1', 'first-page': '40', 'article-title': 'The molecular control of granulocytes and macrophages', 'volume': '204', 'author': 'Metcalf', 'year': '1997', 'journal-title': 'Ciba Found. Symp.'} / Ciba Found. Symp. / The molecular control of granulocytes and macrophages by Metcalf (1997)
  2. 10.1016/S0167-5699(99)01500-5 / Immunol. Today. / Novel trends in neutrophil structure, function and development by Mollinedo (1999)
  3. 10.1016/0167-5699(93)90215-7 / Immunol. Today. / Phagocyte recognition of cells undergoing apoptosis by Savill (1993)
  4. 10.1182/blood.V80.8.2012.2012 / Blood. / Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products by Colotta (1992)
  5. 10.1182/blood.V92.7.2495 / Blood. / Mcl-1 expression in human neutrophilsregulation by cytokines and correlation with cell survival by Moulding (1998)
  6. 10.4049/jimmunol.163.1.412 / J. Immunol. / The murine antiapoptotic protein A1 is induced in inflammatory macrophages and constitutively expressed in neutrophils by Orlofsky (1999)
  7. 10.1182/blood.V87.3.983.bloodjournal873983 / Blood. / A1, a bcl-2 family member, prolongs cell survival and permits myeloid differentiation by Lin (1996)
  8. 10.1002/eji.1830260817 / Eur. J. Immunol. / Expression and function of the Fas receptor on human blood and tissue eosinophils by Hebestreit (1996)
  9. 10.1084/jem.184.2.429 / J. Exp. Med. / Differential expression of Fas (CD95) and Fas ligand on normal human phagocytesimplications for the regulation of apoptosis in neutrophils by Liles (1996)
  10. 10.1111/j.1348-0421.1996.tb01095.x / Microbiol. Immunol. / Involvement of two types of TNF receptor in TNF-α induced neutrophil apoptosis by Gon (1996)
  11. 10.4049/jimmunol.162.3.1692 / J. Immunol. / Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils by Aoshiba (1999)
  12. 10.1074/jbc.273.14.8389 / J. Biol. Chem. / p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils by Frasch (1998)
  13. 10.1182/blood.V84.4.1201.1201 / Blood. / Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils by Iwai (1994)
  14. 10.1182/blood.V89.9.3199 / Blood. / The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage by Sanz (1997)
  15. 10.1006/bbrc.1998.9155 / Biochem. Biophys. Res. Commun. / A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils by Chuang (1998)
  16. 10.1084/jem.188.11.1985 / J. Exp. Med. / Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2–related A1 gene by Hamasaki (1998)
  17. 10.1006/bbrc.1997.6529 / Biochem. Biophys. Res. Commun. / The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils by Hsieh (1997)
  18. 10.1023/A:1023286831246 / J. Clin. Immunol. / Spontaneous and Fas-induced apoptotic cell death in aged neutrophils by Tortorella (1998)
  19. 10.1016/S1074-7613(00)80587-7 / Immunity. / Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia by Traver (1998)
  20. 10.1006/cimm.1998.1339 / Cell. Immunol. / Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis by Fecho (1998)
  21. {'key': '2023072509304597200_R21', 'first-page': 'F85', 'article-title': 'Regulation and function of the JNK subgroup of MAP kinases', 'volume': '1333', 'author': 'Minden', 'year': '1997', 'journal-title': 'Biochim. Biophys. Acta.'} / Biochim. Biophys. Acta. / Regulation and function of the JNK subgroup of MAP kinases by Minden (1997)
  22. 10.1073/pnas.96.26.14943 / Proc. Natl. Acad. Sci. USA. / Constitutive bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival by Ogilvy (1999)
  23. 10.1073/pnas.96.26.14871 / Proc. Natl. Acad. Sci. USA. / Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL by Huang (1999)
  24. 10.1084/jem.187.8.1205 / J. Exp. Med. / Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity by Schneider (1998)
  25. 10.2144/98255st03 / Biotechniques. / Rapid hybridoma screening method for the identification of monoclonal antibodies to low abundance cytoplasmic proteins by O'Reilly (1998)
  26. {'key': '2023072509304597200_R26', 'article-title': 'The pro-apoptotic BH3-only protein Bim is expressed in hemopoietic, epithelial, neuronal and germ cells', 'volume': 'In press', 'author': "O'Reilly", 'year': '2000', 'journal-title': 'Am. J. Pathol'} / Am. J. Pathol / The pro-apoptotic BH3-only protein Bim is expressed in hemopoietic, epithelial, neuronal and germ cells by O'Reilly (2000)
  27. 10.1002/j.1460-2075.1995.tb00304.x / EMBO (Eur. Mol. Biol. Organ.) J. / Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis by Strasser (1995)
  28. 10.1038/nm0198-031 / Nat. Med. / Downregulation of Fas ligand by shedding by Tanaka (1998)
  29. 10.1038/nm0198-021 / Nat. Med. / Fas ligand—caught between Scylla and Charybdis by Strasser (1998)
  30. 10.1073/pnas.90.5.1756 / Proc. Natl. Acad. Sci. USA. / Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice by Adachi (1993)
  31. 10.1093/emboj/17.6.1675 / EMBO (Eur. Mol. Biol. Organ.) J. / Two CD95 (APO-1/Fas) signaling pathways by Scaffidi (1998)
  32. 10.1084/jem.183.3.1031 / J. Exp. Med. / A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection by Rodriguez (1996)
  33. 10.1038/nm0196-80 / Nat. Med. / Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice by Lacronique (1996)
  34. 10.1084/jem.191.1.195 / J. Exp. Med. / Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of fas or FADD/MORT1 signalingimplications for cancer therapy by Newton (2000)
  35. 10.1093/emboj/17.3.706 / EMBO (Eur. Mol. Biol. Organ.) J. / A dominant interfering mutant of FADD/Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes by Newton (1998)
  36. 10.1038/sj.onc.1200848 / Oncogene. / Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death by Huang (1997)
  37. 10.4049/jimmunol.155.10.4644 / J. Immunol. / Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma by Memon (1995)
  38. 10.4049/jimmunol.154.5.2023 / J. Immunol. / Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity by Chiu (1995)
  39. 10.1038/nm0596-574 / Nat. Med. / Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells by Friesen (1996)
  40. 10.1126/science.270.5240.1326 / Science. / Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis by Xia (1995)
  41. 10.1038/380075a0 / Nature. / Requirements for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis by Verheij (1996)
  42. 10.1126/science.275.5296.90 / Science. / Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways by Ichijo (1997)
  43. 10.1016/S0163-7258(99)00008-X / Pharmacol. Ther. / p38 mitogen-activated protein kinase inhibitors—mechanisms and therapeutic potentials by Lee (1999)
  44. 10.1182/blood.V93.1.341 / Blood. / Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha by Suzuki (1999)
  45. 10.4049/jimmunol.162.6.3601 / J. Immunol. / Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes by Ottonello (1999)
  46. 10.4049/jimmunol.161.9.4484 / J. Immunol. / Chemotactic activity of soluble Fas ligand against phagocytes by Seino (1998)
  47. 10.1038/23730 / Nature. / Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis by Yin (1999)
  48. 10.1016/S1074-7613(00)80478-1 / Immunity. / The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens by Van Parijs (1998)
  49. 10.1016/S1074-7613(00)80111-9 / Immunity. / Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice by Tsutsui (1999)
  50. 10.1084/jem.179.3.1047 / J. Exp. Med. / bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages by Lagasse (1994)
  51. {'key': '2023072509304597200_R51', 'first-page': '2928', 'article-title': 'Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression', 'volume': '54', 'author': 'Kondo', 'year': '1994', 'journal-title': 'Cancer Res.'} / Cancer Res. / Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression by Kondo (1994)
  52. {'key': '2023072509304597200_R52', 'first-page': '3331', 'article-title': 'Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells', 'volume': '57', 'author': 'Villunger', 'year': '1997', 'journal-title': 'Cancer Res.'} / Cancer Res. / Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells by Villunger (1997)
  53. 10.1038/32681 / Nature. / Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 by Zhang (1998)
  54. 10.1016/S1074-7613(00)80609-3 / Immunity. / Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally by Varfolomeev (1998)
  55. {'key': '2023072509304597200_R55', 'first-page': '324', 'article-title': 'Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy', 'volume': '55', 'author': 'de Haan', 'year': '1995', 'journal-title': 'Cancer Res.'} / Cancer Res. / Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy by de Haan (1995)
  56. 10.1016/S0301-472X(98)00041-1 / Exp. Hematol. / Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells by Bai (1999)
  57. 10.1016/0092-8674(93)80065-M / Cell. / Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair by Veis (1993)
  58. 10.1126/science.7878471 / Science. / Massive cell death of immature hematopoietic cells and neurons in Bcl-x deficient mice by Motoyama (1995)
  59. 10.1073/pnas.95.21.12424 / Proc. Natl. Acad. Sci. USA. / Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant by Print (1998)
  60. 10.1073/pnas.96.23.13330 / Proc. Natl. Acad. Sci. USA. / Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosisa general mechanism to accumulate effector cells in inflammation by Dibbert (1999)
  61. 10.1126/science.286.5445.1735 / Science. / Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity by Bouillet (1999)
  62. 10.1016/S1097-2765(00)80456-6 / Mol. Cell. / The pro-apoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex by Puthalakath (1999)
  63. 10.1172/JCI5257 / J. Clin. Invest. / Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils by Nick (1999)
  64. 10.1093/emboj/18.23.6845 / EMBO (Eur. Mol. Biol. Organ.) J. / Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation by Bulavin (1999)
  65. 10.1074/jbc.272.33.20490 / J. Biol. Chem. / Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase by Kummer (1997)
  66. 10.1073/pnas.93.24.13814 / Proc. Natl. Acad. Sci. USA. / Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes by Graves (1996)
  67. 10.1101/gad.13.4.400 / Genes Dev. / Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis by Grumont (1999)
  68. 10.1074/jbc.273.26.16415 / J. Biol. Chem. / Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase by Nemoto (1998)
  69. 10.1084/jem.191.5.859 / J. Exp. Med. / Deficiency of the stress kinase p38α results in embryonic lethalitycharacterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells by Allen (2000)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 12:48 p.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 6:44 a.m.)
Indexed 3 months, 1 week ago (May 18, 2025, 12:22 p.m.)
Issued 25 years ago (Aug. 28, 2000)
Published 25 years ago (Aug. 28, 2000)
Published Online 25 years ago (Aug. 28, 2000)
Published Print 24 years, 11 months ago (Sept. 5, 2000)
Funders 0

None

@article{Villunger_2000, title={FAS Ligand, Bcl-2, Granulocyte Colony-Stimulating Factor, and p38 Mitogen-Activated Protein Kinase}, volume={192}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.192.5.647}, DOI={10.1084/jem.192.5.647}, number={5}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Villunger, Andreas and O’Reilly, Lorraine A. and Holler, Nils and Adams, Jerry and Strasser, Andreas}, year={2000}, month=aug, pages={647–658} }